Anticholinergic Toxicity: Key Clinical Points
Anticholinergic toxicity presents with a classic constellation of peripheral and central antimuscarinic effects, best remembered as "Red as a beet, dry as a bone, hot as a hare, blind as a bat, mad as a hatter, full as a flask" 1.
Clinical Features
Vital Signs & Autonomic Dysfunction
- Temperature: Elevated (can reach up to 46°C) 1
- Heart rate: Tachycardia (though rare cases of sinus pause/asystole have been reported) 1, 2
- Blood pressure: Mild hypertension 1
- Respirations: Tachypnea 1
Physical Examination Findings
- Skin: Hot, dry, erythematous (flushed) 1
- Pupils: Mydriasis (dilated pupils) 1
- Mucous membranes: Dry 1
- Gastrointestinal: Hypoactive or absent bowel sounds, urinary retention 1
- Mental status: Agitated delirium, confusion, hallucinations, psychomotor agitation 1, 3
Neuromuscular Findings
- Muscle tone: Normal (distinguishes from serotonin syndrome and neuroleptic malignant syndrome) 1
- Reflexes: Slowed, hyporeflexic 1
Common Causative Agents
Over 600 compounds possess anticholinergic properties 4, 5. The most clinically relevant include:
- Antihistamines: Diphenhydramine 1, 6
- Tricyclic antidepressants 1, 4
- Muscle relaxants: Cyclobenzaprine 6
- Overactive bladder agents: Oxybutynin 6
- Antipsychotics 4
- Sleep aids and cold preparations 1, 4
- Atropine and topical mydriatics 4
- Plants: Jimson weed 4
- Street drugs: Scopolamine 3
Critical Point on Elderly Patients
In older adults, anticholinergic toxicity frequently results from cumulative burden of multiple medications rather than single-agent overdose 6, 7. These medications cause decline in cognition, functional status, falls, delirium, emergency department visits, and hospitalizations 6.
Management Algorithm
1. Immediate Stabilization
- Discontinue precipitating drug(s) 1
- Supportive care with focus on:
- Airway protection if severely altered
- Intravenous hydration
- Continuous cardiac monitoring
2. Agitation Control
Benzodiazepines are first-line for agitation 1. Physical restraint should be minimized as it increases heat production and worsens hyperthermia.
3. Specific Antidote: Physostigmine
Physostigmine is indicated for severe anticholinergic toxicity with agitated delirium, seizures, or life-threatening manifestations 1, 8, 9.
- Evidence: Patients receiving physostigmine alone had significantly lower intubation rates (1.9% vs 8.4%) compared to other treatments 8
- Onset: Decreases agitation within 15-20 minutes 9
- Dosing: Administer slowly intravenously with cardiac monitoring
- Contraindications: Prolonged QRS interval, cardiac conduction abnormalities 1
Common pitfall: Despite proven efficacy and safety, physostigmine is underutilized—only 12.4% of anticholinergic toxicity patients receive it, while 28.7% receive benzodiazepines alone 8.
4. Alternative When Physostigmine Unavailable
Rivastigmine (oral capsules preferred over transdermal patch) can be used when physostigmine is unavailable 10. Oral rivastigmine 6 mg was more effective than transdermal patches, with only 32% requiring additional parenteral treatment versus 73% with patches 10. Galantamine has also been used off-label with success 3.
5. Hyperthermia Management
Treat hyperthermia aggressively as it is rapidly life-threatening:
- Benzodiazepines to reduce muscular activity 1
- External cooling measures
- In severe cases: paralysis with nondepolarizing agents (vecuronium, rocuronium) and intubation 1
- Avoid succinylcholine due to risk of hyperkalemia and rhabdomyolysis 1
- Antipyretics are NOT efficacious (fever is from muscular activity, not hypothalamic dysregulation) 1
6. Specific Cardiac Considerations
For prolonged QRS or dysrhythmias (particularly with tricyclic antidepressants): Administer sodium bicarbonate 1.
Diagnostic Challenges
Critical caveat: Standard urine toxicology screening often misses anticholinergic agents 3. Diagnosis relies on:
- Pattern recognition of the clinical toxidrome
- Detailed medication history (including over-the-counter drugs)
- Advanced testing (GC-MS) when diagnosis unclear 3
Not all patients exhibit all classic features—mild cases may present with isolated tachycardia and agitation without fever 1.
Special Populations
Elderly
Deprescribe strongly anticholinergic medications in older adults 6. The anticholinergic burden causes:
- Cognitive decline and dementia progression
- Functional impairment and decreased ADL scores
- Increased fall risk
- Emergency department visits and hospitalizations
- Higher healthcare costs 6
Pediatric
Onset typically occurs within 0.5-24 hours of exposure 1. The same management principles apply with weight-based dosing adjustments.